- Home
- PROV vs CLYM Comparison
PROV vs CLYM Comparison
Compare PROV & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- CLYM
- Stock Information
- Founded
- PROV 1956
- CLYM 2018
- Country
- PROV United States
- CLYM United States
- Employees
- PROV N/A
- CLYM N/A
- Industry
- PROV Savings Institutions
- CLYM
- Sector
- PROV Finance
- CLYM
- Exchange
- PROV Nasdaq
- CLYM NYSE
- Market Cap
- PROV 100.7M
- CLYM 83.8M
- IPO Year
- PROV 1996
- CLYM 2021
- Fundamental
- Price
- PROV $15.32
- CLYM $1.45
- Analyst Decision
- PROV Hold
- CLYM Buy
- Analyst Count
- PROV 1
- CLYM 1
- Target Price
- PROV $16.50
- CLYM $10.00
- AVG Volume (30 Days)
- PROV 6.6K
- CLYM 209.3K
- Earning Date
- PROV 07-28-2025
- CLYM 08-13-2025
- Dividend Yield
- PROV 3.68%
- CLYM N/A
- EPS Growth
- PROV N/A
- CLYM N/A
- EPS
- PROV 0.93
- CLYM N/A
- Revenue
- PROV $39,666,000.00
- CLYM N/A
- Revenue This Year
- PROV $3.06
- CLYM N/A
- Revenue Next Year
- PROV $9.15
- CLYM N/A
- P/E Ratio
- PROV $16.35
- CLYM N/A
- Revenue Growth
- PROV 1.90
- CLYM N/A
- 52 Week Low
- PROV $12.91
- CLYM $1.05
- 52 Week High
- PROV $16.70
- CLYM $8.79
- Technical
- Relative Strength Index (RSI)
- PROV 44.84
- CLYM N/A
- Support Level
- PROV $15.01
- CLYM N/A
- Resistance Level
- PROV $15.48
- CLYM N/A
- Average True Range (ATR)
- PROV 0.25
- CLYM 0.00
- MACD
- PROV -0.05
- CLYM 0.00
- Stochastic Oscillator
- PROV 38.75
- CLYM 0.00
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.